A locally advanced breast cancer that achieved pCR with pertuzumab, trastuzumab and docetaxel: Case report

Medicine and Dentistry

• Axilla 33%
• Axillary Lymph Node 33%
• Biological Product 33%
• Breast 33%
• Breast Carcinoma 33%
• Case Report 33%
• Character 33%
• Combination Therapy 100%
• Diagnosis 33%
• Docetaxel 100%
• Edema 33%
• Epidermal Growth Factor Receptor 2 33%
• Estrogen Receptor 33%
• Examination 33%
• Female 33%
• Gamma Urogastrone 33%
• Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer 33%
• Locally Advanced Breast Cancer 66%
• Lymphadenopathy 33%
• Neoplasm 33%
• Patient 33%
• Primary Tumor 33%
• Progesterone Receptor 33%
• Skin 33%
• Specimen 33%
• Surgery 33%
• Trastuzumab 100%